Non-invasive in vivo measurements of metabolic alterations in the type 2 diabetic brain by <sup>1</sup>H magnetic resonance spectroscopy.
Ontology highlight
ABSTRACT: Type 2 diabetes (T2D) is a complex chronic metabolic disorder characterized by hyperglycemia because of insulin resistance. Diabetes with chronic hyperglycemia may alter brain metabolism, including brain glucose and neurotransmitter levels; however, detailed, longitudinal studies of metabolic alterations in T2D are lacking. To shed insight, here, we characterized the consequences of poorly controlled hyperglycemia on neurochemical profiles that reflect metabolic alterations of the brain in both humans and animal models of T2D. Using in vivo 1H magnetic resonance spectroscopy, we quantified 12 metabolites cross-sectionally in T2D patients and 20 metabolites longitudinally in T2D db/db mice versus db+ controls. We found significantly elevated brain glucose (91%, p < 0.001), taurin
SUBMITTER: Choi IY
PROVIDER: S-EPMC11093888 | biostudies-literature | 2024 May
REPOSITORIES: biostudies-literature
ACCESS DATA